Dyadic (NASDAQ: DYAI) Secures $3M Gates Foundation Grant to Advance Global Vaccines & Therapeutics with C1 Fungal Platform – More Stocks Inside
We are pleased to share an exciting update on Dyadic International, Inc. (NASDAQ: DYAI), a company at the forefront of transforming vaccine development through its proprietary C1 filamentous fungal platform.…